Neoplasm Metastasis: all 3,564 studies
Page 9 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian CancerRecruitingNCT04585958Phase 1
- The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RecruitingNCT04585750Phase 1/2
- Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort StudyNot yet recruitingNCT04562727Not applicable
- Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver MetastasesRecruitingNCT04520737Not applicable
- Mobile Health Application (PACT) to Improve Engagement in Advance Care PlanningRecruitingNCT04515810Not applicable
- 68Ga-FAPI PET/CT in Patients With Various Types of CancerRecruitingNCT04499365Early Phase 1
- The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid MalignanciesRecruitingNCT04492735
- Safety and Early Signs of Efficacy of IL12-L19L19.RecruitingNCT04471987Phase 1
- An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid TumorsRecruitingNCT04443088Phase 1
- Comparison of FDG and FAPI in Patients With Various Types of CancerRecruitingNCT04416165Not applicable
- Local Ablative Therapy for Patients With Multiple (4-10) Brain MetastasesRecruitingNCT04397978
- Anti-HER2 Therapy + Fulvestrant/Capecitabine in Women With HR+, HER2+, Non-visceral Metastases Stage IV Breast CancerNot yet recruitingNCT04337658Phase 3
- A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)RecruitingNCT04333706Phase 1/2
- PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerRecruitingNCT04329494Phase 1
- Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic CancersRecruitingNCT04295863Phase 1
- Immune Resistance Interrogation StudyRecruitingNCT04243720
- Cetuximab as Salvage Therapy in Patients With Neo Wild-type RAS/RAF Metastatic Colorectal Cancer With Liver Metastases.RecruitingNCT04189055Phase 2
- Tumoral Bone Strength Assessment by Numerical Simulation Using Quantitative CT : the MEKANOS StudyRecruitingNCT04170634
- Evaluation of Prognostic Factors: From Breast Cancer to Bone MetastasesRecruitingNCT04167605
- SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsRecruitingNCT04150042Phase 1
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsRecruitingNCT04119024Phase 1
- A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.RecruitingNCT04116541Phase 2
- A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsRecruitingNCT04094610Phase 1/2
- Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data RegistryRecruitingNCT04085029
- BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver MetastasesRecruitingNCT04079049Phase 3
- Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic CancerRecruitingNCT04068649Phase 2
- Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver MetastasesNot yet recruitingNCT04062721Phase 1
- Percutaneous Vertebroplasty Using Rotary Cutter for Bone MetastasesRecruitingNCT04017728Not applicable
- MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)RecruitingNCT04004559
- Gut Microbiome Dynamics in Metastasized or Irresectable Colorectal CancerRecruitingNCT03941080
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsRecruitingNCT03911388Phase 1
- Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ TrialRecruitingNCT03907475Phase 2
- Body Mass Index (BMI) and Quality of Life (QoL) in Cancer PatientsRecruitingNCT03873064
- The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid CancerRecruitingNCT03841617Phase 2
- A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid TumorsRecruitingNCT03797391Phase 1/2
- Stereotactic Radiotherapy for Cerebral Metastases with Recent Hemorrhagic SignalRecruitingNCT03696680Phase 2
- Evaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb PerfusionRecruitingNCT03685890Phase 1/2
- Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal CancerRecruitingNCT03577665Not applicable
- Southeast Netherlands Advanced Metastatic Breast Cancer RegistryRecruitingNCT03577197
- Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal CancerRecruitingNCT03566355Not applicable
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/2
- Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal CancerRecruitingNCT03494946Not applicable
- Living Donor Liver Transplantation With Two Stage Hepatectomy for Patients With Isolated, Irresectable Colorectal Liver MetastasesRecruitingNCT03488953Not applicable
- New MRI Biomarkers in Head and Neck CancersRecruitingNCT03483337
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Bone Metastases Database of Patients Treated Surgically for Impending or Pathologic Fracture of Long BonesRecruitingNCT03416959
- Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite TumorsRecruitingNCT03392233Phase 2
- Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal CancerNot yet recruitingNCT03367884Not applicable
- A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRCRecruitingNCT03303495Phase 3
- Neurocognitive Impact and Dose-Effect Relationship of Hippocampal Avoidance During Whole Brain Radiotherapy Plus Simultaneous Integrated Boost - A Prospective Follow-up StudyRecruitingNCT03223675Not applicable
- Distribution of Lymph Node Metastases in Esophageal CarcinomaRecruitingNCT03222895
- Neurocognition in Patients With Multiple Brain Metastases Treated With RadiosurgeryRecruitingNCT03184038Not applicable
- Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic LesionsRecruitingNCT03129412Phase 2
- Integrative Analysis of CRC Liver MetastasisRecruitingNCT02917707
- Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver MetastasisRecruitingNCT02886104Not applicable
- Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverRecruitingNCT02885753Phase 3
- A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)RecruitingNCT02819882
- Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching HostRecruitingNCT02732860
- A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function DeclineRecruitingNCT02504788Not applicable
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruitingNCT02474160
- PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line ChemotherapyNot yet recruitingNCT02448576Not applicable
- Cancer Experience Registry (CER) for Cancer Patients and CaregiversRecruitingNCT02333604
- Screening for Synchronous Metastases in Colorectal Cancer With DW-MRI (SERENADE)RecruitingNCT02246634Not applicable
- Observational Study to Evaluate Long-Term Outcome in Hip ArthroplastyRecruitingNCT02230826
- Stereotactic Body Radiation Therapy (SBRT) for Unresectable Liver MetastasesRecruitingNCT02185443Phase 2
- Personalized Oncogenomics (POG) Program of British ColumbiaRecruitingNCT02155621Not applicable
- Local Treatment With RP for Newly-diagnosed mPCaRecruitingNCT02138721Not applicable
- T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerRecruitingNCT02133196Phase 2
- A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver MetastasisRecruitingNCT02102789Phase 3
- AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.RecruitingNCT02102165Not applicable
- Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatmentRecruitingNCT02029001Phase 2
- HaemoDYNAMICs in Primary and Secondary HypertensionRecruitingNCT01742702
- Liver Transplantation and Colorectal CancerRecruitingNCT01479608Not applicable
- Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"RecruitingNCT01365169Not applicable
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling by invitationNCT00068003
- Using a Mirror in the Second Stage of Labor: Effects on Duration and Birth ExperienceCompletedNCT06648161Not applicableResults posted
- Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC PatientsCompletedNCT06119217Phase 2Results posted
- A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose CombinationsActive, not recruitingNCT06101134Phase 2Results posted
- Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.CompletedNCT06086340Results posted
- Psilocybin-Assisted Therapy for the Treatment of Cancer-Related Anxiety in Patients With Metastatic CancerCompletedNCT05847686Phase 1/2Results posted
- NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursTerminatedNCT05714553Phase 1/2Results posted
- Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in FinlandCompletedNCT05701007Results posted
- Immunotherapy With Non-Ablative Radiation in Previously Untreated Patients With Stage IV NSCLCTerminatedNCT05691829Phase 2Results posted
- A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal CancerTerminatedNCT05678257Phase 2Results posted
- Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic CancerCompletedNCT05673811Phase 2Results posted
- A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).CompletedNCT05578872Phase 1/2Results posted
- A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid TumorsTerminatedNCT05572684Phase 1/2Results posted
- Design and Testing of a Web-Based Tool for the Improvement of End-of-Life Planning in Patients With Advanced CancerCompletedNCT05564468Not applicableResults posted
- Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic AdenocarcinomaTerminatedNCT05525286Phase 1/2Results posted
- CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's SarcomaActive, not recruitingNCT05440786Phase 2Results posted
- A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)Active, not recruitingNCT05288166Phase 3Results posted
- First-in-Human Study of TAK-280 in Participants With Solid TumorsTerminatedNCT05220098Phase 1/2Results posted
- A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic CancerActive, not recruitingNCT05215769Not applicableResults posted
- Advance Care Planning in the Emergency DepartmentCompletedNCT05209880Not applicableResults posted
- First in Human Study of M1069 in Advanced Solid TumorsTerminatedNCT05198349Phase 1Results posted
- Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast CancerActive, not recruitingNCT05169567Phase 3Results posted
- Niraparib in the Treatment of Patients With Advanced PALB2 Mutated TumorsTerminatedNCT05169437Phase 2Results posted
- A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody) in Patients With Solid TumorsTerminatedNCT05159388Phase 1/2Results posted
- A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)Active, not recruitingNCT05104866Phase 3Results posted
- Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)CompletedNCT05103358Phase 2Results posted